Scientists identify potential biomarkers associated with positive immunotherapy response

FHS
June 26, 2023
6:05 pm

Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.

Severe PTSD characterized by lower oxytocin and higher vasopressin levels

Research finds PTSD marked by reduced oxytocin and elevated vasopressin, suggesting AVP/OT ratios as potential biomarkers for diagnosis and treatment response.

August 2, 2024

Blood test may predict MS development, UCSF research reveals

In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of

April 22, 2024

Exposure to interpersonal violence throughout childhood increases the risk of developing diabetes

According to the results of a new study in the American Journal of Preventive Medicine, published by Elsevier, exposure to interpersonal violence throughout childhood or

August 18, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.